Efficacy of adjuvant XELOX and FOLFOX6 chemotherapy after D2 dissection for gastric cancer.
about
Expression of multidrug resistance-associated proteins and their relation to postoperative individualized chemotherapy in gastric cancer.Significance of multidrug resistance gene-related proteins in the postoperative chemotherapy of gastric cancerFactors associated with early recurrence after curative surgery for gastric cancerThe Efficacy of Adjuvant FOLFOX6 for Patients With Gastric Cancer after D2 Lymphadenectomy: A Propensity Score-matched AnalysisCharacteristics and prognosis of gastric cancer in patients aged ≥ 70 years.Impact of pre-existing type-2 diabetes on patient outcomes after radical resection for gastric cancer: a retrospective cohort study.A review of capecitabine-based adjuvant therapy for gastric cancer in the Chinese population.
P2860
Q34346821-BE9F5B7C-8C85-4E76-8AB4-45FB141B8584Q34733148-63AD54D5-D36E-4F99-876C-A0E121E453D7Q35625410-C53BD11F-CA7C-421C-A032-9205F5246CEEQ36837966-48B8B1B0-1DE6-4AC4-A359-9E41CA762FD0Q37241575-8029AE53-BE4D-4B2C-8051-077E251F2DE8Q44467868-511F04DE-6ED4-4F72-8397-7F360F7891D9Q47291560-700332F1-38A4-4C08-9532-41B1EE523639
P2860
Efficacy of adjuvant XELOX and FOLFOX6 chemotherapy after D2 dissection for gastric cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Efficacy of adjuvant XELOX and ...... dissection for gastric cancer.
@en
type
label
Efficacy of adjuvant XELOX and ...... dissection for gastric cancer.
@en
prefLabel
Efficacy of adjuvant XELOX and ...... dissection for gastric cancer.
@en
P2093
P2860
P356
P1476
Efficacy of adjuvant XELOX and ...... dissection for gastric cancer.
@en
P2093
Chang-Hua Zhang
David D Smith
Guang-Kai Xia
Roderich E Schwarz
Yu-Long He
Zhe-Wei Wei
P2860
P304
P356
10.3748/WJG.V19.I21.3309
P407
P577
2013-06-01T00:00:00Z